The Business Times
The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

'No benefit' from hydroxychloroquine for Covid-19: major UK trial

Published Fri, Jun 5, 2020 · 02:40 PM
Share this article.

[PARIS] A major British trial of hydroxychloroquine has found it has "no benefit" for patients hospitalised with Covid-19, researchers said Friday, announcing they had halted tests of the drug.

"We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with Covid-19," said a statement from the chief investigators in the randomised clinical trial, which is run by the University of Oxford and is testing a number of potential treatments for the new coronavirus.

They added they would stop recruiting patients to the hydroxychloroquine part of the trial "with immediate effect".

AFP

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here